Christopher Cunningham is named as a lobbyist on federal disclosure filings for 2 clients through Boehringer Ingelheim USA Corporation, Formerly Reported As Boehringer Ingelheim Pharmaceuticals, INC and 1 other registrant. The most recent filing naming them posted in October 2026. Issues reported include Health Issues, Medicare/Medicaid, Budget/Appropriations and Taxation/Internal Revenue Code.
Filers must list covered executive or legislative branch positions held. As filed:
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| DAIICHI SANKYO INC | DAIICHI SANKYO, INC. | Q3 2026 | Taxation/Internal Revenue Code, Medicare/Medicaid, Health Issues |
| BOEHRINGER INGELHEIM USA CORPORATION | BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC | Q2 2025 | Medicare/Medicaid, Health Issues, Budget/Appropriations |
| Year | Clients | Registrants |
|---|---|---|
| 2026 | 1 | 1 |
| 2025 | 1 | 1 |
| Year | Items | Total |
|---|---|---|
| 2026 | 5 | $3K |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Christopher Cunningham. See the Capitol Clarity rankings and method.